Axonex AI Group Limited Class A Company Profile
NASDAQ: AXNXConsumer DiscretionaryBusiness ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Axonex AI Group at a glance
Axonex AI Group Limited Class A (NASDAQ: AXNX) is a Business Services company in the Consumer Discretionary sector headquartered in Irvine, CA, Hong Kong. Axonex AI Group is led by Mr. Raymond W. Cohen and employs about 797 people. The company's shares have traded publicly since 2025.
At a market capitalization of $5.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001998560, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Axonex AI Group do?
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California. As of November 15, 2024, Axonics, Inc. operates as a subsidiary of Boston Scientific Corporation.
Business description based on the company's public filings.
Company information
- Legal name
- Axonex AI Group Limited Class A
- Ticker
- NASDAQ: AXNX
- Sector
- Consumer Discretionary
- Industry
- Business Services
- CEO
- Mr. Raymond W. Cohen
- Employees
- 797
- Headquarters
- 26 Technology Drive, Irvine, CA, Hong Kong
- Phone
- 949 396 6322
- Website
- axonics.com
- IPO year
- 2025
- Market cap
- $5.28M
- SEC CIK
- 0001998560
Companies similar to Axonex AI Group
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| KRKR36Kr Holdings Inc. ADR | 2.56 | -3.40% | $5.05M | vs AXNX |
| BAOSBaosheng Media Group Holdings Limited | 0.1166 | -8.91% | $3.89M | vs AXNX |
| OLBThe OLB Group Inc. | 0.115 | -4.33% | $3.59M | vs AXNX |
| TGLTreasure Global Inc. | 3.88 | -5.13% | $3.56M | vs AXNX |
| CJMBCallan JMB Inc. | 0.301 | -7.10% | $3.21M | vs AXNX |
| QHQuhuo Limited Class A | 3.06 | -1.29% | $8.42M | vs AXNX |
| UKUcommune International Ltd Class A | 1.10 | -9.84% | $745.75K | vs AXNX |
| XHLDTEN Holdings Inc. | 0.6402 | -3.03% | $9.90M | vs AXNX |